Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?-Reference-Cited by-同舟云学术

Cyclophosphamide-based metronomic chemotherapy: After 10 years of experience, where do we stand and where are we going?

Published:2012-04 Issue:1 Volume:82 Page:40-50
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Penel Nicolas,Adenis Antoine,Bocci Guido

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference84 articles.

1. The anti-angiogenic basis of metronomic chemotherapy;Kerbel;Nat Rev Cancer,2004

2. Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugs;Bocci;Cancer Res,2002

3. Acrolein: unwanted side product or contribution to antiangiogenic properties of metronomic cyclophosphamide therapy?;Günther;J Cell Mol Med,2008

4. Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy;Bocci;Proc Natl Acad Sci U S A,2003

5. A multitargeted, metronomic, and maximum-tolerated dose “chemo-switch” regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer;Pietras;J Clin Oncol,2005

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Survival of Cellulose Sulphate-Encapsulated Cells and Metronomic Ifosfamide Control Tumour Growth in Pancreatic Cancer Models—A Prelude to Treating Solid Tumours Effectively in Pets and Humans;Life;2023-12-18

2. Maintenance Chemotherapy for Patients with Rhabdomyosarcoma;Cancers;2023-08-07

3. Long-term adjuvant metronomic chemotherapy in a dog with recurrent maxillofacial osteosarcoma;Veterinární medicína;2023-05-29

4. The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies;Frontiers in Pharmacology;2023-02-22

5. Angiogenesis Inhibitors in the Treatment of Cancer;Handbook of Cancer and Immunology;2023